TransDigm heads into the week after its Q2 earnings beat in a conflicted position — results ran ahead of expectations, guidance went up, yet the stock still trades roughly 22% below consensus price targets as analysts immediately cut their numbers.
Q2 tells a good story on the surface. Revenue hit $2.54 billion for the quarter, up from $2.15 billion a year earlier, and EBITDA as defined margins came in at 52.6%. The company raised full-year sales guidance by $420 million at the midpoint and lifted EBITDA guidance by $210 million. Commercial aftermarket growth rebounded from softer recent quarters, defense revenues grew at a double-digit rate, and CEO Mike Lisman noted bookings across all three channels meaningfully surpassed shipments — a forward-looking signal the order book is building. Shares responded with a 3.6% gain on Tuesday, adding to a 3.2% rise on the week.
The caution is in the margin trajectory. The bear case centres on a projected EBITDA margin that is seen declining around 140 basis points year-over-year for the full year, with the recently acquired Simmonds business still dragging on mix. Multiple analysts moved on the same day earnings dropped. Stifel maintained its Buy but cut its price target from $1,650 to $1,525. RBC Capital and Susquehanna both held their ratings and trimmed targets to $1,350, leaving the mean consensus target at $1,525 — still roughly 28% above the current price of $1,191. Wells Fargo, which initiated in April at Equal-Weight with a $1,200 target, remains the most cautious voice on the Street. The aggregate picture is a Street that still skews constructive but is visibly more selective about what it will pay for. The analyst recommendation divergence score ranks at the 92nd percentile, meaning this name sees wider disagreement than nearly all peers — an unusually wide spread between conviction bulls and cautious holders.
Positioning in the lending market tells a story of very little drama. Short interest is just 1.77% of the free float — not a meaningful bearish position by any measure — and it has actually been declining, falling 4% over the past week and pulling back from a brief run above one million shares shorted in mid-April. Borrow availability is ample, with cost to borrow running at just 0.44% annualised. The ORTEX short score sits at 31.5, near the low end of its recent range and well below any level suggesting short-side pressure. If anything, the short-side story here is the absence of one.
Options tell a more interesting tale. The put/call ratio has dropped to 1.90, which sounds defensively positioned in absolute terms — but it is now materially below its 20-day average of 2.38, sitting roughly 1.2 standard deviations below that mean. Through late March and most of April, the PCR was running above 2.5 and touched 3.1 in early April. The recent compression in that ratio signals a shift: investors are buying fewer puts relative to calls compared to where they were a month ago. That re-rating in options sentiment aligns with the earnings beat — traders who were hedging heavily into the print appear to have unwound some of that protection.
Founder and Chairman Walter Howley sold approximately $8.7 million of stock on April 20, across multiple tranches at prices between $1,260 and $1,272. The trades carry low significance scores and follow a pattern of programmatic selling typical of a founder with a long-tenured position. Net insider activity over the past 90 days is actually positive in share terms at roughly 14,900 shares — suggesting that while the Chairman has been trimming, other insiders have been adding on balance. Capital Research, the largest institutional holder with 23.2% of shares, added 342,000 shares in Q1, and BlackRock added over 100,000 through April 30. The institutional base is net buyers at the margin.
The central tension to watch is whether the guidance raise — and the re-acceleration in commercial aftermarket — proves durable given the CEO's explicit caveat about Middle East flight disruptions. Lisman noted RPM growth slowed to 2.1% globally in March due to regional conflict, even as ex-Middle East growth ran at 8%. TDG's aftermarket revenue is where the business earns its margins, and if that softening persists into Q3, the gap between the raised guidance and analyst estimates may narrow in the wrong direction. The next quarterly print will be less about topline momentum and more about whether the margin recovery story holds as acquisition dilution from Simmonds and the newly closed Jet Parts Engineering and Victor Sierra deals begins to be absorbed.
See the live data behind this article on ORTEX.
Open TDG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
